Test Price
2,800 AED✅ Home Collection Available
FLNB Gene Spondylocarpotarsal Synostosis Syndrome Genetic Test in UAE | 2800 AED | DHA-Compliant
Executive Summary & Core Metrics
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM. Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by a DHA-licensed consultant. Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Genetic Test detects rare mutations in the FLNB gene responsible for spondylocarpotarsal synostosis syndrome, a multisystem skeletal dysplasia. It identifies precise genetic variants to guide orthopedic, rheumatologic, and genetic counseling decisions with DHA-approved methodology.
| Feature | Our Test | Closest Alternative (Sanger Single-Gene) |
|---|---|---|
| Precision | Full FLNB coding & splice-site coverage via NGS | Limited to a few exons; may miss deep intronic/CNVs |
| Method | NGS + Sanger confirmation of pathogenic variants, ISO 9001:2015 | Sanger sequencing of pre-selected regions |
| Turnaround | 3–4 Weeks (rapid clinical reporting) | 4–6 Weeks |
Physician Insight & Safety Protocols
Note from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403): Spondylocarpotarsal synostosis syndrome often presents with progressive vertebral and limb deformities that require a coordinated, long-term care plan. This NGS test provides a definitive molecular diagnosis, but it is not a standalone predictor of disease severity—always correlate results with clinical imaging and physical examination findings.
Clinical Advisory
Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic test results must be interpreted within the full clinical context before any treatment change.
Exclusion Criteria & Emergency Red Flags
- Home Collection Exclusion: Active fever, uncontrolled pain, or any condition requiring immediate hospital monitoring.
- Test Exclusion: Known mosaicism or bone marrow transplant within 90 days—contact our clinical team for alternative strategies.
- Seek ER immediately if you experience: sudden limb weakness, loss of bladder/bowel control, severe neck/back pain with numbness, or acute vision changes—possible spinal cord compromise.
Patient FAQ & Clinical Guidance
1. How is the FLNB NGS test for spondylocarpotarsal synostosis performed and what sample do I need?
The test requires a simple blood draw, a DNA FTA card with a single drop, or previously extracted DNA; our NGS laboratory sequences the entire FLNB coding region and identifies mutations with 99.9% sensitivity.
2. How long does it take to receive results, and who interprets them?
Results are ready in 3 to 4 weeks; a DHA-licensed clinical geneticist provides a comprehensive report and a telephonic consultation is included to explain the findings and guide next steps.
3. Is my genetic data private and compliant with UAE laws?
Absolutely; all samples and genetic data are protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Processing follows ISO 9001:2015 standards with zero data sharing without consent.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – full compliance for genetic data privacy.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – secure handling of electronic health records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring clinical safety and patient consent.
- ISO 9001:2015 certified laboratory (Certificate: INT/EGQ/2509DA/3139).
- DHA Facility License No. 1143 – fully authorized for genetic diagnostic services.
Clinical & Logistical Metadata
| Test Name | FLNB Gene Spondylocarpotarsal Synostosis Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), DNA FTA Card, or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | Q87.8 (Other specified congenital malformation syndromes, not elsewhere classified) |
| LOINC Code | 21658-4 (FLNB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Laboratory Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians